All such lingering doubts, however, were put to rest by the Illinois supreme court. In an unprecedented decision based primarily upon the Restatement (Second) of Torts section 402A, 6 it agreed with the appellate court that blood is a product and that a transfusion is a sale within the meaning of the Restatement. But the supreme court went further and announced that the "unavoidably unsafe" exception of comment k 7 to the Restatement could not provide the hospital with a valid defense. Comment k, according to the supreme court," ... relates only to products which are not impure and which, even if properly prepared, inherently involve substantial risk of injury to the user.'' 8 Since hepatitis-infected blood is by definition impure, comment k could have no bearing on the case. By reading the comment so narrowly, the Illinois supreme court imposed strict liability on hospitals for transfusions of blood carrying the serum hepatitis virus. This Recent Development will briefly trace the development of hospital liability for transfusions of hepatitis-infected blood and will analyze both the impact of Cunningham on that area of the law and the correctness of the Cunningham decision. raised based on RESTATEMENT (SECOND) OF TORTS § 402A, comment k at 353-54 (1965) [hereinafter RESTATEMENT]. See note 7 infra for the full text of comment k.
6. Section 402A provides: Special Liability of Seller of Product for Physical Harm to User or Consumer (1) One who sells any product in a defective condition unreasonably dangerous to the user or consumer or to his property is subject to liability for physical harm thereby caused to the ultimate user or consumer, or to his property, if (a) the seller is engaged in the business of selling such a product, and (b) it is expected to and does reach the user or consumer without substantial change in the condition in which it is sold.
(2) The rule stated in Subsection (1) applies although (a) the seller has exercised all possible care in the preparation and sale of his product, and (b) the user or consumer has not bought the product from or entered into any contractual relation with the seller. RESTATEMENT § 402A, at 347-48 (emphasis added).
7. RESTATEMENT § 402A, comment k at 353-54 provides in full: Unavoidably unsafe products. There are some products which, in the present state of human knowledge, are quite incapable of being made safe for their intended and ordinary use. These are especially common in the field of drugs. An outstanding example is the vaccine for the Pasteur treatment of rabies, which not uncommonly leads to very serious and damaging consequences when it is injected.
Since the disease itself invariably leads to a dreadful death, both the marketing and the use of the vaccine are fully justified, notwithstanding the unavoidable high degree of risk which they involve. Such a product, properly prepared, and accompanied by proper directions and warning, is not defective, nor is it unreasonably dangerous. The same is true of many other drugs, vaccines, and the like, many of which for this very reason cannot legally be sold except to physicians, or under the prescription of a physician. It is also true in particular of many new or experimental drugs as to which, because of lack of time and opportunity for sufficient medical experience, there can be no assurance of safety, or even perhaps of purity of ingredients, but such experience as there is justifies the marketing and use of the drug notwithstanding a medically recognizable risk. The seller of such products, again with the qualification that they are properly prepared and marketed, and proper warning is given, where the situation calls for it, is not to be held to strict liability for unfortunate consequences attending their use, merely because he has undertaken to supply the public with an apparently useful and desirable product, attended with a known but apparently reasonable risk.
8. 47 m. 2d at 456, 266 N.E.2d at 904.
[Vol. 69 The disease that allegedly caused Mrs. Cunningham her anguish has afflicted man for centuries, 9 but not until the 1940's was it discovered that the causative virus could be introduced by the transfusion of blood. 10 While hepatitis is not the only disease that can be transmitted by blood transfusion, 11 it does represent one of the most serious risks associated with this treatment because of its frequency of occurrence, 12 its undetectability, 13 and the present lack of vaccines and other satisfactory methods of prevention. 14 9. For a succinct history of serum hepatitis, see Butterich &: Wilson, Serum Hepatitis -A Historical Perspective and Current Progress, 36 U. MICH. MED. CENTER J. 67 (1970) 10. See R. GRAY, supra note 1, ,r 38.35. 11 . Other diseases that can be transmitted parenterally include malaria, syphilis, measles, and influenza. See Wiener, Medicolegal Aspects of Blood Transfusions, 151 J. A.M.A. 1435, 1438 (1953) . These diseases, however, do not pose the serious threat that hepatitis does because they are readily detected when proper procedures are employed. See Van Wormer, Blood Transfusion Therapy, Pitfalls and Practice, MED. TRIAL TECH. Q., June, 1968, at 57-60. 12. Although there is agreement that the frequency of blood transfusions and the incidence of serum hepatitis resulting therefrom are such that the disease presents a very serious medical problem, the estimates demonstrate considerable divergence of opinion on what the contractual rate actually is. Thus one encounters contentions rang• ing from an infection rate of 3% in whole blood, R. GRAY, supra note I, ,r 38.35, to one of . 2%, Wiener, Prevention of Accidents in Blood Transfusions, 156 J.A.M.A. 1301 , 1305 (1954 Hepatitis, 49 GASTRoENTEROLOGY 23 (1965) . The last cited article is the most complete study of the subject of those listed. In translating these percentages into numbers of patients affected one recent article summarized as follows:
Several studies on representative numbers of recipients of blood transfusions lead to estimates of 30,000 cases of serious overt illness and 1,500 to 3,000 deaths from transfusion-associated viral hepatitis [meaning in this instance serum hepatitis] each year in the United States. However, there is evidence that the reporting of the overt disease is incomplete and that the incidences of illness and mortality that it causes may be much higher. Also, it is estimated that the ratio of subclinical hepatitis cases associated with transfusion to cases of the overt disease may be as high 16, "Although many large efforts have been made to identify blood which has a high risk of transmitting hepatitis, there is still no proved method for identifying the hepatitis carriers." Walsh, Purcell, Morrow, Chanock 8e Schinidt, Posttransfusion Hepatitis After Open-Heart Operations, 211 J.A.M.A. 261, 265 (1970) . This is not to say that no carrier can be identified. Some demonstrate an overt illness that would call for im• mediate disqualification, while others have abnormalities discoverable by means of liver function tests. See Mosley 8e Galambos, supra note 14, at 420. Estimates of detection rates range from 25 to 75%, Butterich 8e Wilson, supra note 9, at 70. One study states that the only laboratory screening test, currently available or proposed, that offers any promise of useful application by blood-banking and transfusion services in identi• fying the long-incubation [serum] form of hepatitis carriers is a test for the presence of Australia antigen in blood. Gocke 8e Kavey, Hepatitis Antigen, Correlation of Disease with Infectivity of Blood Donors, 1 THE LANCET 1055 (1969) . The same study points out that at the current level of sensitivity, only about one-fourth of the cases can be detected by this means. All agree that there exists no certain method of identifying contaminated individuals.
See, e.g., R. GRAY, supra note I, ,r 38.35; Mosley 8e Galambos, supra note 14, at 420; Wiener, supra note 12, at 1305. 17, Mosley 8e Galambos, supra note 14, at 420; Wiener, supra note 12, at 1305. 18, Wiener, supra note 11, at 1438. 19, See, e.g., 279 NEW ENG, J. MED. 1290 MED. (1968 , where the director of a Red Cross Blood Program stated preliminary results from a Massachusetts survey indicated that by "packing" the red blood cells a much lower incidence of hepatitis was achieved. Other factors cited as possible Initigating influences are storage at room temperatures over a period of several months and plasma irradiation. See R. GRAY, supra note 1, ,r 38.35. 20. Butterich 8e Wilson, supra note 9, at 67 states: [B]lood products have been used in large quantities only during the last 30 years , • , [and] there has been a striking rise in the number of cases of serum hepatitis reported yearly. Unlike diseases which are becoming more prevalent for unknown reasons, the increased incidence of serum hepatitis can be traced to epideiniologic factors which we simply have been unable thus far to control. Mosley 8e Galambos, supra note 14, at 429-30, further explains:
The repeated attempts to find processes for inactivating the viruses of hepatitis in pooled plasma have been unavailing. Initially ultraviolet irradiation appeared to be effective as judged by the results of human volunteer experiments. Subsequent [Vol. 69 Thus, although a hospital may be careful in its selection of donors and meticulous in its methods of storage and administration, it is still quite possible that a patient may contract hepatitis and perhaps die if he has been injected with hepatitis-infected blood. The lack of effective methods to discover and eliminate the virus makes it difficult for plaintiffs to prove a failure by hospitals to exercise reasonable diligence. Thus, attempts to hold hospitals liable for transfusions of hepatitis-contaminated blood based on a theory of negligence have been largely unsuccessful. 21 The same want of preventive techniques renders a res ipsa loquitur assertion ineffective. 22 A further obstacle encountered in some jurisdictions is the rule that the doctrine of respondeat superior cannot be used to hold a hospital liable for negligent harm inflicted by a physician or medical employee while rendering professional services. 28 Finally, actions based on a theory of negligence per se 24 or on the hospital's experience .•• has demonstrated that plasma so treated, at least under conditions of commercial porduction, still has a higher than average risk. Similarly, initial work with storage for 6 months at "room" temperature, or under more carefully controlled conditions at 31.6° C (90° F), suggested that such material was safe, but a carefully controlled prospective investigation showed that this process was also ineffective. Irradiated pooled plasma treated with betapropiolactone is reportedly safe, but the study has not been confirmed and the material is commercially unavailable. No effective method for sterilizing fibrinogen or anti-hemophilic globulin preparations is available. See, e.g., Fischer v. Wilmington Gen. Hosp. 51 Del. 554, 149 A.2d 749 (1959); Hiddy v. State, 207 Misc. 207, 137 N.Y.S.2d 334 (Ct. CI. 1955 ), afjd., 2 App. Div. 2d 644, 151 N.Y.S.2d 621 (1956 Parker v. State, 201 Misc. 416, 105 N.Y.S.2d 735 (Ct. Cl. 1951 ), afjd., 280 App. Div. 157, 112 N.Y.S.2d 695, appeal denied, 280 App. Div. 901, 115 N.Y.S.2d 311 (1952 failure to warn the patient of the dangers inherent in a transfusion 25 have not been successful.
21.
The lack of success in negligence suits prompted plaintiffs to base their actions on theories of implied warranty 26 and strict Iiability.27 However, a sale-service dichotomy that developed within the implied warranty doctrine2 8 generally proved fatal to plaintiffs' claims based on that theory. 29 The sale-service dichotomy was first used to defeat a claim for damages resulting from a transfusion of hepatitis-infected blood in Perlmutter v. Beth David Hospital. 30 In that case, the defendant hospital had furnished blood for use in a transfusion. Plaintiff contracted serum hepatitis and sued the hospital for breach of implied warranty. Recovery was denied. The New York Court of Appeals reasoned that the contract between the plaintiff and the defendant hospital was essentially one for services. Moreover, the contract was not divisible even though it provided that the hospital should supply certain "healing materials" 31 such as medicines, drugs, and even blood. The court concluded, therefore, that there was no sale to which an implied warranty could attach.
Perlmutter has unquestionably been the most influential decision in this area of the law. Although often criticized 32 and recently re- 26. For a discussion of the development of the implied warranty theory, see ·w.
PROSSER, supra note 22, § 97, at 678-81.
27. For a discussion of the theory of strict liability, see ·w. PROSSER, supra note 22, § § 74-79, at 506-44, § 87, at 672-85. It should be borne in mind that strict liability does not mean absolute liability. Under the latter theory, causation and harm alone furnish the basis for recovery. See Sweet v. State, 195 Misc. 494, 500-01, 89 N.Y.S.2d 506, 514 (Ct. CI. 1949) . Under strict liability, which is not founded upon negligence, there is still a dual requirement of (1) a defective product that is (2) unreasonably dangerous. See, e.g., REsrATEMENT § 402A; Wade, Strict Tort Liability of Manufacturers, 19 Sw. L.J. 1, 13 (1965) .
28. The sale-service dichotomy is one of the contractural rules associated with implied warranty that is criticized by W. PROSSER, supra note 22, § 95, at 655. Essentially, the sale-service rule states that implied warranties can only attach to a contract for the sale of products. Therefore, if the contract in any particular case is essentially one for services, there is no implied warranty. For e.xamples of the application of this dichotomy in areas other than blood transfusion cases, see Consolidated Timber Co. v. Womack, 132 F.2d 101 (9th Cir. 1942); Child's Dining Hall Co. v. Swingler, 173 Md. 490, 197 A. 105 (1938); Pappanastos v. State Tax Commn., 235 Ala. 50, 177 S. 158 (1937 REv. 830 (1970) ; Note, Sales-jected in a few cases, 33 it has provided the foundation for decisions in the majority of jurisdictions that have adjudicated the issue.H The Cunningham decision, however, may signify an end to that influence. The Illinois supreme court convincingly rejected the holding in Perlmutter that a transfusion of blood is a service rather than the sale of a product. 35 Furthermore, since the Cunningham court deemed blood contaminated with hepatitis an unreasonably dangerous product, 36 a patient contracting the disease by transfusion or other injection may be virtually assured of success in a strict liability action against the hospital. 37
Blood Transfusions-Implied Warranties Under the Uniform Commercial Code, 46 N.D. L. R. Ev. 367 (1970) 
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The extent to which Cunningham will be accepted in other jurisdictions is difficult to determine. Although Perlmutter undoubtedly continues to have considerable influence, Cunningham seems to be in accord with the growing disenchantment of some courts with the Perlmutter rationale 38 as well as with what some commentators have been advocating for several years. 39 Moreover, several states still have no statute or judicial ruling dealing with the issue, 40 and Cunningham may well be influential in those states that are disposed toward the view expressed in that case but are reluctant to effect the groundbreaking themselves.
On the other hand, several considerations tend to diminish the impact that Cunningham may have in other jurisdictions. Twentythree states have enacted statutes that specifically preserve the "service" nature of blood transfusions. 41 Since a sale is usually required brought under strict liability. See REsTATEMENT § 402A, comment n at 356. Comment n appears to limit the availability of the assumption of risk defense to cases in which the plaintiff " ••• discovers the defect and is aware of the danger, and nevertheless proceeds unreasonably to make use of the product." It is doubtful that a patient who is informed of both the need for a blood transfusion and the possibility of hepatitis virus in the blood to be used is acting unreasonably when he chooses to undergo the transfusion. to bring strict liability into play, 42 the effect of these statutes will be to preclude any strict liability cause of action. 43 In addition, the doctrine of sovereign immunity may exempt publicly supported hospitals from the Cunningham approach in many states. 44 There are a great many exceptions to the sovereign immunity rule, however, and it cannot be assumed that the existence of the doctrine in any given state necessarily precludes recovery under the Cunningham analysis. 45 Moreover, the courts have imposed a variety of limitations upon the sovereign immunity doctrine. 46 Furthermore, a court that is willing to accept the Cunningham analysis may also be willing to re-evaluate the doctrine of sovereign immunity and hold ,it inapplicable to blood transfusion cases. 47 Yet conceding all this, the fact that the doctrine of sovereign immunity remains the law in over half of the states 48 implies that the application of Cunningham will, in certain factual settings, thereby be impeded.
A similar concept is the doctrine of charitable immunity, and in those states where it is the law it too will hinder application of a strict-liability theory to blood transfusion cases. 49 Although the trend is clearly in the direction of disapproval 50 and limitation 111 42. See note 6 supra. 43. But there will be no such elimination when there is no requirement of a sale. See Hoffman v. Misericordia Hosp., 439 Pa. 501, 267 A.2d 867 (1970) , discussed in note 33 supra.
44. For a discussion of sovereign immunity as a defense to tort claims, see W. PROSSER, supra note 22, § 125, at 1001-03, § 127, at 1019. 45. For example, military, veterans, and public-service hospitals are subject to suit under the Federal Tort Claims Act, 28 U.S.C. § § 1291, 1346, 1402, 1504, 2110, 2401-02, 2411-12, 2671-80 (1964) . The Act makes the United States liable for the wrongful acts or omissions of federal employees within the scope of their employment "in the same manner and to the same extent as a private individual under like circumstances" under the local law of the place where the tort occurs. 28 U.S.C. § 2674 (1964) .
There are some instances, however, when the Federal Tort Claims Act is not applicable-e.g., when the claim is based upon performance or failure to perform a discretionary function, or when it is based upon an intentional tort, or an act or omission of a governmental employee exercising due care in the execution of a statute or regulation. Members of the armed forces cannot recover when the alleged injury was 46. For example, the hospital may have to be engaged in a "governmental" function as opposed to a "proprietary" one in order to qualify for the immunity. See generally HEALTH LAW CENTER, supra note 45, at 152-54; W. PROSSER, supra note 22, § 125, at 1004-10. 47. For an example of such a judicial re-evaluation that resulted in a holding that the doctrine does not protect public hospitals, see Muskopf v. Corning Hosp. Dist., 55 Cal. 2d 211, 359 P.2d 457, 11 Cal. Rptr. 89 (1961) .
48. I!EALTH LAW CENTER, supra note 45, at 152. An illustrative selection of cases is listed in Annot., 25 A.L.R.2d 203 (1952) .
49. For a discussion of the defense of charitable immunity to tort claims, see W. PROSSER, supra note 22, § 127, at 1019-24.
50. "Where the question of [charitable immunity] has arisen as of first impression May 1971] Recent Developments 1181 of charitable immunity, the doctrine continues to possess sufficient vitality in some jurisdictions 52 to thwart the assertion of a strict-liability argument against charitable entities. 53 Perhaps the most significant of all the factors that will limit the influence of Cunningham is the analytical fragility of the court's reasoning. For though the court took a laudable step forward in discarding the Perlmutter rationale, in doing so it brushed aside a powerful objection to the application of strict liability with very questionable commentary. The basic objection to holding hospitals strictly liable for transfusions of hepatitis-infected blood is based on comment k to section 402A of the Restatement of Torts. Comment k excepts "unavoidably unsafe products" from the rule of strict liability. In order for a product to be unavoidably unsafe, three requirements must be met: (I) all reasonable efforts must be made to make the product safe; (2) proper warnings of possible danger must be given; (3) experience must justify the marketing of the product despite the risk involved. 54 The court added a fourth requirement, however: the product must not be impure. 55 Since hepatitis-infected blood is by definition impure, the court held that it did not fall within the comment k exception.
It is extremely difficult to justify the court's decision to read this additional requirement into comment k. Indeed, the language of comment k standing alone seems to refute thoroughly the court's analysis:
... [A] product properly prepared, and accompanied by .proper directions and warning, is not defective, nor is it unreasonably dangerous ... [when], because of lack of time and opportunity for sufficient medical experience, there can be no assurance of safety, or even perhaps of purity of ingredients, but such experience as there is justifies the marketing and use of the . . . [product] notwithstanding a medically recognizable risk. 56 within recent years, it has been uniformly rejected; in no jurisdiction has the doctrine been adopted by overruling a prior judicial decision recognizing full liability."
HEALm LAw CENTER, supra note 45, at 149. See also C. KRAMER, MEDICAL MALPRACTICE 21-27 (rev. ed. 1965) . W. PROSSER, supra note 22, § 127, at 1024, states that the doctrine "is clearly in full retreat." 51. Even where the doctrine still exists, its vitality is often circumscribed by limitations placed upon it. See generally HEALTH LAw CENTER, supra note 45, at 143-48.
52. For a jurisdiction-by-jurisdiction discussion of immunity rules and decisions, see Annot., 25 A.L.R.2d 29, 142-200 (1952 
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Michigan Law Review [Vol. 69 Thus, comment k specifically applies to the situation in which medical knowledge cannot assure purity of ingredients but the use of the product is justified nonetheless. Notably, the court omitted the portion relating to purity of ingredients from its quotation of comment k.51
Moreover, the comment cites the Pasteur vaccine as an example of a product to which strict liability should not attach. The court distinguished the Pasteur vaccine from hepatitis-infected blood on the ground that the latter is an impure substance while the former is a pure substance. This distinction is factually questionable. The Pasteur vaccine is cultured in the brains of small laboratory animals such as rats, mice, and rabbits. Small particles of brain material are left in the vaccine and it is this brain material that causes harm to recipients of the vaccine. 58 Thus, the Pasteur vaccine is not a "pure" substance; it contains particles of foreign material that occasionally cause seric;ms harm to the recipient just as does hepatitisinfected blood. This fact supports the conclusion that the court was engaged in a mere semantic exercise when it created the "pureimpure" distinction. And in so doing, the court distorted the thrust of comment k. Comment k was intended to prevent the imposition of strict liablility when the value of a medical product outweighs its potential for causing harm by such a substantial degree that the use of the product is justified. 59 Therefore, in deciding whether the comment is applicable in any given situation, a court should determine only whether all reasonable efforts have been made to make the product safe and whether the necessity of administering the product outweighs an unavoidable element of risk to the patient. The fact that all medical efforts to remove the hepatitis virus from the blood have thus far been unsuccessful has already been documented. 60 And the necessity of blood transfusions in modern medicine appears to be substantially on a par with that of the Pasteur vaccine. 61 Therefore, it seems clear that the court erred in adding the 57. 47 Ill. 2d at 456, . "All these vaccines [various rabies vaccines including the Pasteur vaccine] suffer from the presence of a large amount of foreign brain material which is capable of producing encephalitis and paralysis in a certain small proportion of individuals (1:4000 to 1:10,000)." Maccallum, Rabies, in VIRUS AND R.lCKEITSIAL DISEASFS OF MAN 253, 261 (4th ed. 1967) .
59. See RESTATEMENT § 402A, comment k at 353-54, which justifies use of the Pasteur vaccine despite the great risk involved.
60. See notes 15-20 supra and accompanying text. 61. "The development of the modern blood transfusion in the past half-century is recognized by the medical profession as one of its finest achievements. Without today's blood transfusions many of the modern surgical practices would not be possible, and hemorrage would be a far greater cause of death." Note, 42 MINN. L. REV. 640, supra note 32. See also Trout, Blood Transfusions, 73 DICK. L. REv. 201, 212 (1969). requirement that a product must be pure in order for comment k to apply. 62 The application of strict liability in any given situation has always rested heavily upon public-policy considerations. Although the court in Cunningham erroneously distinguished comment k, it was presumably free to reject the comment outright if it found sufficiently compelling reasons to do so. Therefore, an examination of the policy behind the application of strict liability to blood transfusion cases is required before any conclusions can be reached concerning the appropriateness of that doctrine for such cases.
Several commentators have argued that comment k should not except contaminated-blood cases from the scope of Restatement section 402A. 63 The proposition most often asserted is that the financial consquences of a transfusion that results in hepatitis should be borne by hospitals because they are in the best position to insure themselves against the loss. Insurance premium costs could then be absorbed into the general overhead costs of the health centers. In this manner, the cost of a transfusion would be spread to all those who avail themselves of the hospitals' services in the form of higher hospital costs. 64 Additionally, it has been argued that the imposition 62. For a case agreeing that comment k applies to transfusions of impure blood, see Jackson v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967 ), revd. on other grounds, 53 N.J. 138, 249 A.2d 65 (1969 . See also Note, Liability of a Hospital for, Supplying Unpure Blood, 1965 WIS. L. R.Ev. 374, 387-88. 63. See, e.g., Comment, Serum Hepatitis Through Blood Transfusions: A Wrong Without a Remedy?, 24 Sw. L.J. 305 (1970 ; Comment, Strict Liability in Tort for Transfusing Contaminated Blood, 23 ARK. L. R. Ev. 236 (1969) .
64. Comment, 24 Sw. L.J. 305, supra note 63, at 321-25; Comment, 23 ARK. L. R.Ev. 236, supra note 63, at 245-49. This is the loss-spreading system imposed in effect by Cunningham. It should be added that a secondary loss-spreading will occur among those people who have medical insurance. The rise in hospital costs would be followed by a rise in premium rates for medical insurance. However, it is difficult to rely on private medical insurance as a loss-spreading device because many person are simply not covered, often because of their financial status. J. BowER, E. CONNORS, J. MOSHER &: C. HOSPITAL INCOME 48 (1970) [hereinafter HOSPITAL INCOME], demonstrate that payments from uninsured individuals account for approximately 15% of the payments received by hospitals from patients. This estimate was supported in an interview with John Zurgich, Associate Director of University Hospital, The University of Michigan, in Ann Arbor, Michigan, March 19, 1971 [hereinafter Zurgich Interview] .
ROWLEY, HOSPITAL INCOME FLOW-A STUDY OF THE EFFECTS OF SOURCE OF PAYMENT ON
Moreover, even for the majority of patients who do have some type of protection, the coverage is often far from adequate. See, e.g., S. GREENBURG, THE TROUBLED CALLING 132 (1965) , in which the author states:
fllnsurance pays 40 percent of the cost of surgery, 30 percent of the expenditures for the services of obstetricians, less than 10 percent of physicians' out of hospital fees, and little or nothing for other services and supplies. This means that in the course of a year, patients have to pay out of pocket an additional $2.5 billion for hospitalization, $3.5 billion for doctors' services, $3.9 billion for drugs and $4.5 billion for other health services, such as dental care, nursing-home care, and appliances •••• While medical costs have been going up at the rate of 5 to 10 percent a year, the ratio of such costs met by insurance has shown an average annual increase of less than 2 percent. At the same time, insurance premium charges have [Vol. 69 of strict liability would encourage a more rapid discovery of a cure for hepatitis or a means of detecting the virus in blood. 65 The role of tort law as a loss distributor has grown dramatically in recent years. 66 In light of this development, it would seem anomalous to allow a single, unfortunate patient to bear the costs that result from a treatment-a blood transfusion-to which all persons might be subjected. However, before the legal system imposes risk allocation in blood transfusion cases, several questions should be considered. How is this allocation to be achieved? Who should be included within it? Is the tort law the most effective medium for reaching the desired result? The decision in Cunningham can be used as a tool of analysis in answering these questions.
As noted above, the result in Cunningham does effect some risk allocation. 67 The court failed to point out, however, the severe drawbacks that this type of risk allocation entails. Of necessity, the hospitals' losses from some patients' contraction of post-transfusion hepatitis will be defrayed by increased assessments on all their patients. 68 This is true because, unlike most manufacturers and sellers who bear this type of business expense, health centers are not able to modify the blood's characteristics or abstain from selling it altogether when the related financial responsibility becomes so onerous as to make its sale unprofitable. 69 Similarly, the losses suffered by commercial blood banks will be passed on primarily to hospital patients and others in need of blood. 70 been climbing "during the past decade at the rate of 10 percent a year under the impact of rising medical costs and increased utilization. Similarly, F. COOK, THE PLOT AGAINST THE PATIENT 231 (1967) , notes that voluntary insurance has come to a "virtual dead end. • • • After nearly 40 years of trial, the only epitaph that can be written for the . • • program is that it is in no aspect satisfactory or even adequate."
The precise economic impact of this type of loss-spreading is not entirely clear. In some cases the cost of blood alone will be affected, but it seems probable that in many others the increased costs will be allocated among all medical services provided by the hospital. 71 If this is the case, the resulting increase in already rapidly rising medical costs 72 could be very substantial. 73 Furthermore, if the Cunningham theory of strict liability in blood transfusion cases were to be applied to analogous situations such as organ transplants, 74 the economic impact would be even more severe. And as medical costs rise, health care will be placed further beyond the reach of those persons in lower income brackets.
This economic burden on the poor is also a factor that distinguishes the strict liability imposed in Cunningham from that imposed by the courts in other product liability cases. An increase 71. Higher blood prices resulting from an imposition of liability on commercial blood banks will often be reflected only in the price of blood. At the University of Michigan Hospital, for example, it was estimated that the increased cost of blood derived from external sources would be reflected solely in the price charged for blood. On the other hand, if the hospital itself were held liable for hepatitis infection resulting from its own blood supply, those costs would be distributed among all products and services sold by the hospital. Moreover, some private insurers are considering the cancellation of hospital liability insurance entirely, apparently because of the unpredictable possibility of large recoveries. Should this happen, many hospitals and their patients might face an even more serious economic problem. Oberman Interview, supra note 70.
72. See Presidential Prescription for Health, TIME, March 1, 1971, at 11, in which it is stated that since 1960 the average daily cost of hospitalization has risen from $56 to $144. The nation's total health bill has reached $70 billion, more than double that of a decade ago. This now averages $324 per person per year. See also Walsh, Medical Care: As Costs Soar, Support Grows for Major Reform, 166 SCIENCE 1126 ; Crisis Ahead in Medical Care, U.S. NEWS & WoRLD REP., Feb. 26, 1968, at 56; The $60-Billion Crisis over Medical Care, BUSINESS WEEK, Jan. 17, 1970, at 50. 73. There can be no precise estimate of the increase in medical cost resulting from the imposition of liability for transfusing a vitiated serum. However, since "[s]ome 2.5 million hospital patients are transfused annually," F. CooK, supra note 64, at 157, and the incidence of infection may be around 3%, with 30,000 serious cases and up to 3,000 deaths per year (see note 12 supra), the recoveries could well be enough to increase significantly the costs of hospitalization. This is particularly true in light of the fact that awards may well exceed the $50,000 asked for by Mrs. Cunningham in the principal case. With this in mind, it has been predicted that for a 400-bed hospital an average $14 per patient-per day increase would result from the holding in Cunningham. See MODERN HosP., supra note 68, at 35. Since hospital income is based primarily on the number of patient-days it has (Zurgich Interview, supra note 64) the smaller hospitals would experience even larger increases, and notably there is less patient insurance coverage in the rural health centers that have fewer beds than do other centers. See HOSPITAL INCOME, supra note 64, at 25.
One concrete example of how Cunningham has affected blood-drawing institutions can be seen in the rise in insurance rates for a Chicago area blood bank, which experienced a twenty-fold increase in annual premiums ($1,500 to $30,000) following the decision. Letter from Nathan Smith, Executive Director of the Midwest Chapter of the National Hemophilia Foundation, to Richard French, of Howard & French, Chicago, Ill., Feb. 23, 1971 . This increased insurance premium will almost certainly be reflected in an increased cost of blood coming from the Chicago area blood banks.
74. See notes 80-82 infra and accompanying text.
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in the cost of automobiles, candy bars, or even canned meat that results from the imposition of strict liability on the manufacturer of these items does not have the effect of making a necessity of life less available to financially disadvantaged persons. It is submitted that the inability of hospitals to prevent the occurrence of hepatitis coupled with this potential economic impact on the poor renders application of strict liability in tort far less appropriate when hepatitis-infected blood is sold than when ordinary consumer goods are sold. The most desirable result would be to alleviate a recipient's financial burden without substantially increasing the costs of medical care in general. The most obvious way to achieve this result would be to distribute the expenses associated with transfusion-contracted hepatitis among the population as a whole. Since everyone is susceptible to disease and accident, and, correspondingly, the necessity of receiving blood, it is not a harsh result to expect all persons to bear a portion of the expense. The imposition of strict liability on hospitals will spread the costs primarily to the purchasers of hospitalization rather than to the public at large and therefore cannot achieve this result. 75 Another drawback to the Cunningham method of risk allocation is that recovery is predicated upon litigation, or at least the threat of litigation, against the hospital. This procedure inevitably suffers from the economic disadvantages that attorney and court fees diminish a plaintiff's recovery and insurance company profits increase the costs of providing the protection. 76 Moreover, since the poor are generally less aware of their rights and less able to litigate, 77 they are the least likely to be compensated for their losses. Additionally, as noted above, several states continue to hold some hospitals free from tort liability on the grounds of sovereign and charitable immunity. 78 In these states, some patients-again often the most needy -will be left without a remedy if the hospital provides its own blood supply. 79 Thus by raising medical costs and implementing a system 75. See notes 70-73 supra and accompanying text. It should be noted that some secondary loss-spreading among persons other than purchasers of hospitalization is inevitable. For example, medical insurance rates will probably increase as the cost of medical products rises; hence all policy holders will be affected whether or not they actually go to the hospital. Some insurance costs may, in turn, be passed on to the customers of those who purchase the insurance. This secondary loss-spreading, however, is extremely speculative and difficult to measure, and in any event will not be complete loss-spreading since the burden will not fall equally on all people. of risk allocation that will be least accessible to the poor, Cunningham gives the least protection to those persons who need it most.
With
Furthermore, Cunningham may have ramifications in areas of medicine other than the transfusion of blood. For example, if a hospital were to have a patient badly in need of a kidney transplant and the kidney used in the transplant was undetectably diseased, the hospital might well be liable to the patient for any resulting harm. 80 This would be so notwithstanding the fact that the hospital was providing the best possible treatment and the patient's life was extended several years as a result of the operation. Since in many instances the organs capable of being transplanted have grossly undetectable deficiencies, 81 the extension of strict liability to such situations could have the dual effect of further raising hospital costs and reducing the available supply of transplant organs. 82 Indeed, the Cunningham analysis could be applied to medicines, anesthetics, and practically any curative implement containing a hidden defect that can be classified as an impurity.
Finally, the hastening of medical triumphs is not a necessary or even probable consequence of the Cunningham result. Although product safety is without doubt a result toward which the imposition of strict liability is directed, 83 the influence of such liability is questionable when the item sold is virtually unimprovable due to the lack of requisite information and techniques. It seems quite unlikely that the growth of medical knowledge will be quickened by making hospitals guarantors of the purity of substances not yet fully understood. Medical science seems to be making ample progress without the imposition of artificial economic stimuli. 84 And there is evidence that the Cunningham result will promote the 80. Other areas of transplants that could conceivably be affected include removable and built-in prostheses and artificial organs, as well as homotransplants (from either living humans or cadavers) and heterotransplants (from animal to man), Mouzas, spending of funds by medical groups to effect the legislative repeal of that case rather than to find a cure for hepatitis. 85 None of the above drawbacks were discussed or even mentioned by the court in Cunningham. The court seemed to assume that its decision to impose strict liability on hospitals would yield a socially desirable result. 86 But as this Recent Development has attempted to demonstrate, the reverse may well be true. Admittedly, the Cunningham approach avoids the imposition of a staggering financial burden upon a single, unfortunate patient. However, this result has been achieved through a method of risk allocation that lacks efficiency, fails to provide protection for all persons who are in need of it, and leads to further increases in the cost of medical care.
Essentially, a greater diffusion of the costs attributable to the uncontrollable effects of proper medical care is needed; but, as pointed out above, the tort law cannot achieve this goal. It is submitted, therefore, that any decision concerning the allocation of risks for unavoidable medical accidents would more appropriately be made by a legislative body. Thorough committee investigations would enable a legislature to gain a more complete understanding of all the potential ramifications involved in spreading the costs of unavoidable medical accidents than the limited context of litigation will allow. Therefore, a legislature would be in a much better position to make practical and informed judgments about who should receive the needed protection, what products should be covered, and what the financial limits of the protection should be.
It should be recognized that a legislative approach at the state level would probably be impractical because, in order to achieve nationwide loss-spreading, all fifty states would have to enact virtually identical statutes. However, several major proposals for an extensive health care program have already been made at the federal level. 87 There appears to be no reason why a provision for the type of situation involved in Cunningham could not be included in any proposal that is ultimately enacted. Such a legislative approach would not necessarily be a perfect one, but it would be far superior to piecemeal judicial attempts to stretch established standards of responsibility beyond the range of their application and effectiveness. President Nixon's plan would expand and almost entirely replace the present medicaid program. Families on welfare and those in the lowest incomes would have their premiums paid by the Government, while other working poor would pay on a basis scaled upward as income rises. In addition, there would be possible coverage for all persons with "catastrophic" illnesses, i.e., situations involving extremely costly treatments or incapacitations for relatively long durations. S. 1623 , 92d Cong., 1st Sess. (1971 .
See 117 CONG. REc. s. 1496 , H. 77'! (daily ed. Feb. 18, 1971 .
The Aetna Life 8: Casualty proposal, one receiving wide backing from the insurance industry, would provide for the poor and uninsurable to elect minimum benefits through private insurance, with the Government paying the premiums. This would include ambulatory and institutional care, with catastrophic medical expenses gradually being extended to all, starting with the poor. H. R. 4349, 92d Cong., 1st Sess. (1971) . See 117 CONG. REc. S. 1958 (daily ed. Feb. 25, 1971 .
The American Medical Association-backed Fulton-Broyhill bill would be based upon taxation credits and offered on a voluntary basis. Free coverage would be provided for those persons paying $300 or less income tax, while others would be allowed a graded scale of tax credits running from 98% ($301 income tax) to 10% (when taxes exceed $1,300). Minimum benefits would include medical services, hospitalization up to sixty days, and optional benefits including coverage for catastrophic illnesses. H.R. 4960-63, 92d Cong., 1st Sess. (1971) . See 117 CONG. REc. S. 1957 -58 {daily ed. Feb. 25, 1971 .
Senator Jacob Javits' bill would expand medicare's hospitalization and medical benefits. Coverage would eventually be provided for all with a minimal cost for the lowest income earners and up to $495 annually for those earning in excess of $15,000. S. 836, 92d Cong., 1st Sess. (1971) . See 117 CONG. REc. S. 1959 (daily ed. Feb. 25, 1971 .
Congresswoman Martha Griffiths' bill, supported by the AFL-CIO, calls for comprehensive health benefits to all persons residing in the United States for a year or more, 11,ith minimal cost to the lowest income earners and a maximum annual cost in any instance of $50 per individual and $100 per family. H. R. 22, 92d Cong., 1st Sess. (1971) . See 117 CONG. REc. H. 197 (daily ed. Jan. 26, 1971) .
See generally National Health Insurance: The Next Attack on Medical Costs, CHANGING TIMES, Jan. 1971, at 41; The Push Is on for Added Federal Health Aids, U.S. NEWS 8: WORLD REP., Feb. 8, 1971, at 35-6. The scope of this Recent Development does not include a comparison of the relative merits of these programs. However, it is urged that the proposal finally adopted should include provisions to insure adequate recompense for patients who contract hepatitis unavoidably or who suffer any other deleterious effects from the proper administration of modern medical therapy. Presently, because private insurance often furnishes only partial coverage (see note 64 supra), it appears that the Kennedy and Griffiths proposals would be the most amenable to this end.
